Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 31, 2025, titled 'Strides Delivers a Robust Q2FY26 with Highest Ever Quarterly EPSQ2FY26 Operational PAT at ₹1,403m and EPS at ₹15.2, Grew 84% YoY'.